The efficacy and safety of epirubicin and cyclophosphamide combined with pyrotinib in neoadjuvant treatment for HER2-positive breast cancer: A real-world study.
Frontiers in oncology（2023）
Abstract
chictr.org Identifier: ChiCTR1900026061.
MoreTranslated text
Key words
breast cancer,human epidermal growth factor receptor 2 positive,neoadjuvant therapy,pyrotinib,real-world study
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined